Understanding COVID-19 is the key to fighting it
La Jolla Institute for Immunology, one of the leading global organizations dedicated to studying the immune system, has stepped up to provide much needed information and real solutions for the COVID-19 outbreak and to improve how we respond to future emerging infectious diseases. We have launched a multi-lab Coronavirus Taskforce that capitalizes on our competitive advantages of unique skill in infectious disease research, state-of-the-art technology, and being a highly collaborative organization. And we also remain committed to educating the public about immunology research, especially during the COVID-19 pandemic.
While the global COVID-19 vaccination campaign continues, new questions are emerging regarding the more infectious Delta variant that is now dominant in the U.S. and news of “breakthrough infections”. So we’ve put together a Q&A guide on those topics to provide science-based, data-driven answers and have packaged it with our comprehensive e-guide on COVID-19 and the vaccines released in April 2021. These brief, easy-to-understand e-guides will keep you informed and empower you to engage in conversations about the safety and efficacy of these vaccines and the groundbreaking research underway related to fighting COVID-19. Stay informed and lead conversations using LJI’s Delta variant and COVID-19 Vaccines Resource Guides.